{"slideshow_credits": null, "snippet": "The pharmaceutical company, which sells a treatment for immune-related ailments at $28,000 a vial, bought a much cheaper alternative of the drug.", "abstract": "Questcor Pharmaceuticals acquires rights to Synacthen drug from Novartis, agreeing to pay at least $135 million; drug, sold in Europe but not in United States, is similar to Questcor's HP Acthar, used to treat various immune-related ailments.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/06/15/business/questcor-pays-135-million-for-rights-to-competitors-drug.html", "lead_paragraph": "The pharmaceutical company, which sells a treatment for immune-related ailments at $28,000 a vial, bought a much cheaper alternative of the drug.", "headline": {"main": "Questcor Pays $135 Million to Acquire Rights to a Competitor\u2019s Drug", "print_headline": "Questcor Pays $135 Million to Acquire Rights to a Competitor\u2019s Drug"}, "_id": "51bb90457e0d9c0839d2891b", "word_count": "836", "multimedia": [{"height": 126, "url": "images/2013/06/15/business/Quest/Quest-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/06/15/business/Quest/Quest-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 75, "url": "images/2013/06/15/business/Quest/Quest-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/06/15/business/Quest/Quest-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-06-15T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Acthar (Drug)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Questcor Pharmaceuticals Incorporated", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Novartis AG", "name": "organizations", "is_major": "N", "rank": "5"}, {"value": "Immune System", "name": "subject", "is_major": "Y", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "News"}